Balyasny Asset Management’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
|
|||||
|
2025
Q3 | $17.8M | Buy |
|
|||||
|
2025
Q2 | $11.2M | Sell |
|
|||||
|
2025
Q1 | $9.94M | Buy |
|
|||||
|
2024
Q4 | $9.31M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $1.02M | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $2.58M | Sell |
|
|||||
|
2022
Q4 | $17M | Buy |
|
|||||
|
2022
Q3 | $5.03M | Buy |
|
|||||
|
2022
Q2 | $170K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $1.14M | Sell |
|
|||||
|
2020
Q2 | $4.36M | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $1.12M | Sell |
|
|||||
|
2015
Q4 | $4.62M | Buy |
|
|||||
|
2015
Q3 | $1.33M | Buy |
|
|||||
|
2015
Q2 | $1.24M | Buy |
|